ADM Publishes Clinical Study: PRIOME® Oral Care Significantly Reduces Dog Tartar

Summary

ADM has published a clinical study in the journal Animals, demonstrating that the postbiotic strain Lactiplantibacillus plantarum CECT 9161, in its heat-treated form PRIOME® oral care, positively impacts oral health in dogs. The study involved 60 healthy adult dogs and showed a significant 10% reduction in dental plaque for those receiving a high dose of the postbiotic. This marks the first canine clinical trial indicating PRIOME® oral care’s potential to reduce dental plaque and support the oral microbiome in dogs.Reuters

Impact Analysis

The publication of this clinical study by ADM represents a product milestone, potentially expanding their market share in the pet care industry. First-order effects include enhanced credibility and competitive advantage in offering scientifically backed oral care solutions for dogs, likely driving demand and sales growth for PRIOME® oral care. Second-order effects might influence peer companies in the pet health sector to innovate or improve their product offerings to compete. Risks involve the need for continued R&D investment and the potential for competitors to develop similar products, thereby diluting ADM’s market presence.Reuters